DOWNEY BRUCE 4
4 · C4 Therapeutics, Inc. · Filed Oct 6, 2020
Insider Transaction Report
Form 4
DOWNEY BRUCE
Director
Transactions
- Conversion
Common Stock
2020-10-06+237,148→ 237,148 total - Conversion
Series A Preferred Stock
2020-10-06−2,000,000→ 0 total→ Common Stock (237,148 underlying) - Conversion
Common Stock
2020-10-06+252,394→ 489,542 total - Conversion
Series B Preferred Stock
2020-10-06−2,128,571→ 0 total→ Common Stock (252,394 underlying)
Footnotes (1)
- [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.